ArticleClinical drug investigation2018

Cost-Effectiveness of Elbasvir/Grazoprevir Versus Daclatasvir Plus Asunaprevir in Patients with Chronic Hepatitis C Virus Genotype 1b Infection in China.

Pingyu Chen et al.PubMed ↗Publisher ↗

No numbers read from the abstract.